Skip to main content
Equibles

Driehaus Capital Management LLC

Position in MNPR — Monopar Therapeutics

CIK 938206 Chicago, IL
Back to MNPR Full portfolio

Position in MNPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,781,263
+$5,964,646 QoQ
Shares Held
84,040
+153.5% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MNPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,707,249,767 across 60 Biotechnology names. MNPR ranks #48 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
 6,845,276 $322,001,783
2 PRAX
Praxis Precision Medicines, Inc.
 959,048 $321,079,679
3 XENE
Xenon Pharmaceuticals Inc.
 4,418,557 $266,704,100
4 SYRE
Spyre Therapeutics, Inc.
 2,799,166 $248,509,957
5
6,463,551 $241,866,078
6
1,740,101 $230,963,605
7 EWTX
Edgewise Therapeutics, Inc.
 4,728,623 $192,123,952
8 SEPN
Septerna, Inc.
 4,433,058 $148,463,112

All Filings in MNPR

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,781,263 84,040
2026-03-31 $1,816,617 33,156
2025-12-31 $2,201,589 33,715
2025-09-30 $5,278,822 64,636